Comparative Pharmacology
Head-to-head clinical analysis: AMINOACETIC ACID 1 5 IN PLASTIC CONTAINER versus RESECTISOL.
Peer-Reviewed Evidence
Head-to-head clinical analysis: AMINOACETIC ACID 1 5 IN PLASTIC CONTAINER versus RESECTISOL.
AMINOACETIC ACID 1.5% IN PLASTIC CONTAINER vs RESECTISOL
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Aminoacetic acid (glycine) acts as an inhibitory neurotransmitter in the central nervous system and is involved in various metabolic processes. As a 1.5% solution in plastic container, it provides free amino acid for parenteral nutrition, contributing to protein synthesis and maintenance of nitrogen balance.
Acetic acid acts as a sclerosing agent by inducing protein denaturation and inflammatory response, leading to fibrosis and obliteration of vascular channels. It also has antimicrobial properties by disrupting cell membranes.
Intravenous infusion of 1.5% aminoacetic acid solution. Typical adult dose: 500 mL to 1000 mL infused over 2 to 4 hours as needed, based on clinical response and electrolyte balance.
Adults: 1–2 mL/kg intravenously once daily.
None Documented
None Documented
1-2 hours; prolonged in renal impairment (up to 8-10 hours if GFR <30 mL/min).
30–45 min; prolonged to 2–4 hours in hepatic impairment or with concurrent halothane.
Renal: >95% unchanged; tubular reabsorption is minimal. Biliary/fecal: <5%.
Primarily renal excretion of unchanged drug (≥90%); <5% fecal.
Category C
Category C
Irrigating Solution
Irrigating Solution